These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 25155601)
1. Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains. Lee YB; Lee JH; Lee DH; Cho H; Ahn H; Choi WM; Cho YY; Lee M; Yoo JJ; Cho Y; Cho EJ; Yu SJ; Kim YJ; Yoon JH; Kim CY; Lee HS Antimicrob Agents Chemother; 2014 Nov; 58(11):6710-6. PubMed ID: 25155601 [TBL] [Abstract][Full Text] [Related]
2. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy. Park JG; Park SY Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269 [TBL] [Abstract][Full Text] [Related]
3. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance. Yang HJ; Lee JH; Kim YJ; Yoon JH; Lee HS J Med Virol; 2012 Mar; 84(3):424-30. PubMed ID: 22246827 [TBL] [Abstract][Full Text] [Related]
4. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial. Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946 [TBL] [Abstract][Full Text] [Related]
5. Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response. Woo HY; Park JY; Bae SH; Kim CW; Jang JY; Tak WY; Kim DJ; Kim IH; Heo J; Ahn SH Clin Mol Hepatol; 2020 Jul; 26(3):352-363. PubMed ID: 32460460 [TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. Yang DH; Xie YJ; Zhao NF; Pan HY; Li MW; Huang HJ World J Gastroenterol; 2015 Mar; 21(9):2746-53. PubMed ID: 25759545 [TBL] [Abstract][Full Text] [Related]
7. Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients. Shao J; Liu Y; Liu LM; Chen R; Zhao L; Zhou Y; Li L; Li X; Li J; Xu D J Infect Dev Ctries; 2021 Jan; 15(1):131-140. PubMed ID: 33571155 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir. Ze E; Baek EK; Lee JJ; Chung HW; Ahn DG; Cho HJ; Kwon JC; Kim HJ; Lee H Clin Mol Hepatol; 2014 Sep; 20(3):267-73. PubMed ID: 25320730 [TBL] [Abstract][Full Text] [Related]
9. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy. Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI J Gastroenterol Hepatol; 2010 Aug; 25(8):1374-80. PubMed ID: 20659226 [TBL] [Abstract][Full Text] [Related]
10. Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B. Kang SH; Yim HJ; Kim HR; Kang K; Suh SJ; Lee HJ; Yoon EL; Kim JH; Seo YS; Yeon JE; Byun KS J Clin Gastroenterol; 2014; 48(10):889-95. PubMed ID: 24440937 [TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B. Park MS; Kim BK; Kim KS; Kim JK; Kim SU; Park JY; Kim DY; Baartarkhuu O; Han KH; Chon CY; Ahn SH Clin Mol Hepatol; 2013 Mar; 19(1):29-35. PubMed ID: 23593607 [TBL] [Abstract][Full Text] [Related]
12. Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies. Kim HS; Yim HJ; Jang MK; Park JW; Suh SJ; Seo YS; Kim JH; Kim BH; Park SJ; Lee SH; Kim SG; Kim YS; Lee JI; Lee JW; Kim IH; Kim TY; Kim JW; Jeong SH; Jung YK; Park H; Hwang SG; World J Gastroenterol; 2015 Oct; 21(38):10874-82. PubMed ID: 26478678 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection. Lee YB; Lee JH; Choi WM; Cho YY; Yoo JJ; Lee M; Lee DH; Cho Y; Yu SJ; Kim YJ; Yoon JH; Kim CY; Lee HS Antimicrob Agents Chemother; 2013 Dec; 57(12):6325-32. PubMed ID: 24100506 [TBL] [Abstract][Full Text] [Related]
14. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures. Kim YJ; Sinn DH; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH World J Gastroenterol; 2012 Dec; 18(47):6996-7002. PubMed ID: 23322999 [TBL] [Abstract][Full Text] [Related]
15. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures. Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029 [TBL] [Abstract][Full Text] [Related]
16. Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir. Kim BG; Jung SW; Kim EH; Kim JH; Park JH; Sung SJ; Park BR; Kim MH; Kim CJ; Lee BU; Park JH; Jeong ID; Bang SJ; Shin JW; Park NH J Gastroenterol Hepatol; 2015 Oct; 30(10):1514-21. PubMed ID: 25973716 [TBL] [Abstract][Full Text] [Related]
17. Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B. Chung GE; Kim W; Lee KL; Hwang SY; Lee JH; Kim HY; Jung YJ; Kim D; Jeong JB; Kim BG; Kim YJ; Yoon JH; Lee HS Dig Dis Sci; 2011 Jul; 56(7):2130-6. PubMed ID: 21253834 [TBL] [Abstract][Full Text] [Related]
18. Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy. Ha M; Zhang G; Diao S; Lin M; Wu J; Sun L; She H; Shen L; Huang C; Shen W; Huang Z Intern Med; 2012; 51(12):1509-15. PubMed ID: 22728482 [TBL] [Abstract][Full Text] [Related]
19. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Patterson SJ; George J; Strasser SI; Lee AU; Sievert W; Nicoll AJ; Desmond PV; Roberts SK; Locarnini S; Bowden S; Angus PW Gut; 2011 Feb; 60(2):247-54. PubMed ID: 21036792 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs. Suzuki F; Suzuki Y; Hosaka T; Sezaki H; Akuta N; Fujiyama S; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Mineta R; Suzuki Y; Kumada H J Gastroenterol; 2017 May; 52(5):641-651. PubMed ID: 27699721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]